Arrowhead Pharmaceuticals, Inc.
USD71.65
-2.65 (-3.57%)
CEO
Christopher R. Anzalone
IPO Date
1993-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$74.35
Prev. Close
$74.30
Day Low
$71.10
Day High
$74.89
52W Low
$14.30
52W High
$87.83
Market Cap
$10.09B
Volume
2.41M
| 0 |
| $0.00 |
| 14 May 2026 | Lu Hongbo | director | S-Sale | Disposed | 2,970 | $76.88 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 3,208 | $70.11 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 1,157 | $70.45 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 8,730 | $71.92 |
| 24 Apr 2026 | Hamilton James C | Chief Medical Officer | S-Sale | Disposed | 10,000 | $75.00 |
| 9 Mar 2026 | Hamilton James C | Chief Medical Officer | S-Sale | Disposed | 10,000 | $64.19 |
| 8 Jan 2026 | Hamilton James C | Chief Medical Officer | A-Award | Acquired | 75,000 | $0.00 |
| 8 Jan 2026 | Apel Daniel Joseph | Chief Financial Officer | A-Award | Acquired | 75,000 | $0.00 |